Aalborg Universitetshospital; Neurologisk Afdeling og Neurofysiologisk Afdeling; Skleroseamb.

Aalborg 9000

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early